A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by Published Comorbidity Summary Measures.
A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by Published Comorbidity Summary Measures.
复制标题
一种评估已发布的合并症总结措施所实现的样本预后平衡的简单方法。
DOI:
10.1111/1475-6773.12276
复制
发表时间:
2015
影响因子:
3.4
通讯作者:
Wong,Yu-Ning
中科院分区:
文献类型:
--
作者:
Egleston,BrianL;Uzzo,RobertG;Beck,JRobert;Wong,Yu-Ning
ObjectiveTo demonstrate how a researcher can investigate the appropriateness of a published comorbidity summary measure for use with a given sample.Data SourceSurveillance, Epidemiology, and End Results linked to Medicare claims data.Study DesignWe examined Kaplan–Meier estimated survival curves for four diseases within strata of a comorbidity summary measure, the Charlson Comorbidity Index.Data CollectionWe identified individuals with early‐stage kidney cancer diagnosed from 1995 to 2009. We recorded comorbidities present in the year before diagnosis.Principal FindingsThe use of many comorbidity summary measures is valid under appropriate conditions. One condition is that the relationships of the comorbidities with the outcome of interest in a researcher's own population are comparable to the relationships in a published algorithm's population. The original comorbidity weights from the Charlson Comorbidity Index seemed adequate for three of the diseases in our sample. We found evidence that the Charlson Comorbidity Index might underestimate the impact of one disease in our sample.ConclusionExamination of survival curves within strata defined by a comorbidity summary measure can be a useful tool for determining whether a published method appropriately accounts for comorbidities. A comorbidity score is only as good as those variables included.